Definitive Contract HDTRA118C0028

Award Date 9/26/18
Potential Completion Date 3/25/21
Potential Value $989K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Cambridge, MA 02138, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, HDTRA117P0004, was made by the Defense Threat Reduction Agency (DTRA) to Nano Terra, Inc., a self-certified small disadvantaged business, for a Small Business Innovation Research (SBIR) Phase I research project. The contract has a firm fixed price of $149,986.83 and a performance period ending on January 11, 2018. The award is set aside for total small business participation. No additional details about the specific products or services being delivered under this...
This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Nanobiosym Inc., a for-profit woman-owned small business. The contract, valued at $2,050,000.00, is for a base period with no set-aside designation. The contract type is a definitive contract with cost-no-fee pricing. The place of performance is East Cambridge, Massachusetts. Nanobiosym Inc. has been awarded federal contracts and grants in the past. Without additional details on the original...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a Small Business Innovation Research (SBIR) Phase I contract to Nano Terra, Inc., a self-certified small disadvantaged business, for research and development on a topic related to chemical/biological defense. The firm-fixed-price contract, with a potential value of $149,756.40, was awarded on October 1, 2018 and is scheduled for completion by March 31, 2019. This SBIR Phase I contract is set...
The U.S. Defense Threat Reduction Agency (DTRA) awarded a $1,507,783.93 Small Business Innovation Research (SBIR) Phase II contract to Arzeda Corp to conduct research on the "Computational Design of Enzymatic Prophylactics and/or Therapeutics for Chemical Warfare Nerve Agents." This definitive, firm-fixed-price contract has an ultimate completion date of August 28, 2025. The SBIR program provides funding to small businesses to conduct research and development that has the potential for...
This federal contract was awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Nano Terra, Inc., a self-certified small disadvantaged business, for a SBIR (Small Business Innovation Research) Phase I research project. The contract has a firm fixed price of $149,894.81 and a completion date of March 30, 2018. The contract was set aside for small businesses. The SBIR Phase I research project likely involves the development of innovative products or...
<p>The U.S. Defense Threat Reduction Agency (DTRA) awarded a $12,202,250.58 Cost Plus Fixed Fee contract to Synergene Therapeutics Inc., a small business, for the application of a nanocomplex technology to the active permeation of the blood-brain barrier (BBB). This is a Definitive Contract, and the ultimate completion date is July 6, 2025. The contract is a Small Business Set Aside and was awarded on July 7, 2020 under the STTR Phase III research program.</p>
This is a $1,024,383.24 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Threat Reduction Agency (DTRA) to Systems &amp; Technology Research LLC (STR), a mid-tier technology company. The contract is for research and development work on predicting emergent science and technology. As a prime contractor, STR has received prior awards from DARPA, the Department of the Air Force, and the Office of the Secretary of Defense for specialized technical services and...
This federal contract award HDTRA115P0024 was issued by the Defense Threat Reduction Agency (DTRA), a defense agency, to Agiltron, Inc., a for-profit manufacturer, for SBIR Phase I research under a total small business set-aside. The contract is a firm-fixed-price purchase order with a ceiling value of $149,623.03 and an ultimate completion date of March 11, 2016. The contract is associated with the SBIR (Small Business Innovation Research) program, which provides funding for small businesses to...
<p>This is a $149,987.54 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Nano Terra, Inc., a self-certified small disadvantaged business, for a SBIR Phase I research project. The award is for the &quot;SBIR PHASE I DHP H161-010-0050&quot; effort, which falls under the SBIR (Small Business Innovation Research) program. The contract has a performance period from August 15, 2016 to March 16, 2017 and is designated as a Total Small Business set-aside.</p>
This is a $147,976.50 firm fixed-price purchase order awarded by the Defense Threat Reduction Agency (DTRA) to Daktari Diagnostics, Inc., a self-certified small disadvantaged business, for a SBIR Phase I research project. The contract is set aside for small businesses. The work will be performed in Cambridge, MA and the ultimate completion date is October 10, 2017. This SBIR Phase I contract is part of DTRA's broader SBIR program, which provides funding to small businesses for research and...

This federal contract award was issued by the Defense Threat Reduction Agency (DTRA) to Nano Terra, Inc., a self-certified small disadvantaged business organization, for the development of dermal medical countermeasures against chemical weapons exposure. The $988,789.00 contract is a Phase II Small Business Innovation Research (SBIR) award with a cost-plus-fixed-fee pricing type. The contract is designated as a total small business set-aside and has a completion date of March 25, 2021. The place of performance is in Cambridge, Massachusetts. The contract appears to be part of the agency's efforts to address the Coronavirus COVID-19 national emergency.

Generated 3/21/24, 5:48 PM